From May 11–15, HYQURE Biotech will attend the 2026 ASGCT Annual Meeting in Boston, joining global peers at one of the most influential gatherings in the CGT field.
During the meeting, HYQURE Biotech will be exhibiting at Booth 1061, where we look forward to engaging with global partners and sharing real-world progress from China's CGT ecosystem, including advancements in IIT frameworks, CMC capabilities, clinical translation, and industrialization.
2026 BIO-Europe Spring
At BIO-Europe Spring on March 24, our colleague Souvik shared insights on contract drug development and biosafety solutions, focusing on how biopharma companies can accelerate development while maintaining high standards in viral safety, quality control, and global regulatory compliance.
As development timelines tighten and regulatory expectations continue to rise, the need for reliable, science-driven biosafety support has never been greater.